Novo: FREHEMGO Haemophilia A Prophylaxis Wins Positive CHMP Opinion for EU Approval
Novo has secured a positive CHMP opinion for FREHEMGO® (denecimig) to treat haemophilia A in adults and children, offering the first FVIIIa mimetic with once-monthly, bi-weekly, and weekly dosing options in a pre-filled pen.
